Taking Care of your Herd
Armenta Ltd., an Agtech company, is developing innovative therapies to transform the standard of care for dairy cattle diseases. Our first target indication, mastitis, is a significant economic burden on dairy farms. It reduces milk yield and quality and increases culling rates, causing more than $2B in lost annual revenue in the U.S. and more than $1.5B in the E.U.
Armenta’s APT-based solution offers increased milk yield after calving, profitability throughout the lactation period, reduced impact of Mastitis on milk yield & quality, udder protection during the dry period and increased milk yield in the next lactation.
Armenta’s APT-based solution shown to produce new blood vessels, reduce inflammation and improve tissue functioning with positive long-term effects.
Armenta aims to dramatically reduce the monetary losses from these pathologies, with the focus on a non-antibiotic mastitis therapy.